CFSAN carb survey
This article was originally published in The Tan Sheet
Executive Summary
An FDA study reveals that 61% of consumers "have heard of" omega-3 fatty acids, compared to 95% who have heard of saturated fat and 67% who have heard of trans fat, the Center for Food Safety & Applied Nutrition announces Nov. 22. "Fats and Carbs: A Snapshot of Consumer Knowledge from a Recent FDA survey" is the center's ninth Health and Diet Survey, conducted "to measure public awareness, knowledge, attitudes and reported behavior" related to nutrition. The random-digit-dialing telephone survey questioned a "nationally representative" sample of 1,798 consumers from October 2004 to January 2005. Data show 53% of consumers tried low carb products, while 30% are unlikely to try such products despite having heard of them. Among those limiting carbs in their diet, 54% do so to lose weight while 37% do so "for other purposes." CFSAN also finds that "calories and fat are considered more important than carb in losing weight" by consumers, with 61% trying to limit fat intake, 48% trying to limit calories and 41% trying to limit carbs...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.